Trials / Conditions / 13-valent Pneumococcal Vaccine
13-valent Pneumococcal Vaccine
5 registered clinical trials studyying 13-valent Pneumococcal Vaccine.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, NCT04078997 | University of Liverpool | — |
| Completed | Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. NCT01193335 | Pfizer | Phase 4 |
| Completed | Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddle NCT01026038 | Pfizer | Phase 3 |
| Completed | Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Childre NCT00743652 | Pfizer | Phase 3 |
| Completed | Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults NCT00744263 | Pfizer | Phase 4 |